Itau Unibanco Holding S.A. Denali Therapeutics Inc. Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$26.28 - $33.92 $29,696 - $38,329	-1,130 Reduced 80.83%	268 $7,000
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $14,361 - $21,307	-553 Reduced 28.34%	1,398 $43,000
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $62 - $105	3 Added 0.15%	1,951 $57,000
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $66,823 - $86,326	1,569 Added 413.98%	1,948 $88,000
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $484 - $782	10 Added 2.71%	379 $19,000
Q2 2021 Aug 17, 2021	BUY	$50.3 - $78.44 $18,560 - $28,944	369 New	369 $29,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.